Prostatic Neoplasms: all 6,484 studies

Page 22 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.

• Sipuleucel-T in Metastatic Castrate Resistant Prostate CancerTerminatedNCT01338012Phase 2Results posted
• Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate CancerTerminatedNCT01335204Phase 1/2Results posted
• A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate CancerCompletedNCT01331083Phase 2Results posted
• Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate CancerTerminatedNCT01326312Phase 2Results posted
• Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal CancersCompletedNCT01325961Not applicableResults posted
• Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate CancerCompletedNCT01325311Phase 2Results posted
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerCompletedNCT01322490Phase 3Results posted
• Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in RussiaCompletedNCT01320735Results posted
• Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate CancerCompletedNCT01317641Phase 1/2Results posted
• Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate CancerCompletedNCT01317199Phase 1/2Results posted
• IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenCompletedNCT01314118Phase 2Results posted
• Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate CancerTerminatedNCT01313559Phase 2Results posted
• Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer PatientsTerminatedNCT01313273Phase 3Results posted
• S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyCompletedNCT01309672Phase 2Results posted
• Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerCompletedNCT01308580Phase 3Results posted
• Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT01308567Phase 3Results posted
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerCompletedNCT01306890Results posted
• A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone TherapyCompletedNCT01302041Phase 2Results posted
• 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate CancerCompletedNCT01296672Phase 4Results posted
• Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate CaCompletedNCT01289067Phase 2Results posted
• A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerCompletedNCT01288911Phase 2Results posted
• Hypofractionated Stereotactic Body Radiation Therapy (SBRT)CompletedNCT01288534Phase 2Results posted
• Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyCompletedNCT01270880Phase 2Results posted
• Saracatinib in Treating Patients With Prostate CancerTerminatedNCT01267266Phase 2Results posted
• Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA MethylationCompletedNCT01265953Not applicableResults posted
• Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With DocetaxelCompletedNCT01260688Phase 2Results posted
• Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mgCompletedNCT01257425Phase 2Results posted
• Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted TherapiesCompletedNCT01254864Phase 2Results posted
• Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With DocetaxelTerminatedNCT01253642Phase 2Results posted
• Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerCompletedNCT01251861Phase 2Results posted
• Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate CancerCompletedNCT01250717Phase 2Results posted
• CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using VitesseCompletedNCT01248741Not applicableResults posted
• A Degarelix Trial in Patients With Prostate CancerTerminatedNCT01242748Phase 3Results posted
• F-18 Sodium Fluoride in Prostate CancerCompletedNCT01240551Phase 2Results posted
• Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceCompletedNCT01238172Phase 3Results posted
• A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGONCompletedNCT01234350Results posted
• Sulforaphane in Treating Patients With Recurrent Prostate CancerCompletedNCT01228084Phase 2Results posted
• Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate CancerCompletedNCT01220973Phase 2Results posted
• A Study of Degarelix in Taiwanese Patients With Prostate CancerCompletedNCT01220869Phase 3Results posted
• Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean PatientsCompletedNCT01215513Phase 3Results posted
• Metformin in Castration-Resistant Prostate CancerTerminatedNCT01215032Phase 2Results posted
• A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerCompletedNCT01212991Phase 3Results posted
• PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate CancerCompletedNCT01205646Not applicableResults posted
• A Study of Olaratumab (IMC-3G3) in Prostate CancerCompletedNCT01204710Phase 2Results posted
• Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate CancerTerminatedNCT01200810Phase 2Results posted
• Abiraterone Post Ketoconazole for Prostate CancerCompletedNCT01199146Phase 2Results posted
• Neoadjuvant Ipilimumab in Prostate CancerCompletedNCT01194271Phase 2Results posted
• Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.CompletedNCT01193257Phase 3Results posted
• Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate CancerCompletedNCT01193244Phase 3Results posted
• GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate CancerTerminatedNCT01176513Phase 2Results posted
• Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-TCompletedNCT01174368Phase 2Results posted
• Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)CompletedNCT01171898Phase 1/2Results posted
• Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate CancerTerminatedNCT01163084Phase 1/2Results posted
• Digoxin for Recurrent Prostate CancerCompletedNCT01162135Phase 2Results posted
• Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue AdministrationCompletedNCT01161563Phase 4Results posted
• QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEACompletedNCT01147965Phase 1/2Results posted
• Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT01145508Phase 2Results posted
• Evaluate Recovery of Testosterone for Patients Using EligardCompletedNCT01136226Phase 4Results posted
• Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate CancerCompletedNCT01133704Phase 3Results posted
• Genistein in Treating Patients With Prostate CancerTerminatedNCT01126879Phase 2Results posted
• Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerCompletedNCT01120236Phase 2Results posted
• ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate CancerTerminatedNCT01119118Phase 2Results posted
• Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)CompletedNCT01118741Not applicableResults posted
• A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)CompletedNCT01106352Phase 1/2Results posted
• L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer SurvivorsCompletedNCT01105130Phase 2Results posted
• Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate CancerTerminatedNCT01093183Phase 1/2Results posted
• Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of EnzalutamideCompletedNCT01091103Phase 2Results posted
• A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)CompletedNCT01090765Phase 1/2Results posted
• Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate CancerCompletedNCT01088529Phase 2Results posted
• A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate CancerCompletedNCT01084759Not applicableResults posted
• Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT01084655Phase 1/2Results posted
• Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate CancerCompletedNCT01083771Not applicableResults posted
• Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to ChemotherapyCompletedNCT01083368Phase 1/2Results posted
• Global Performance Evaluation of the AMS CONTINUUM™ DeviceCompletedNCT01083199Phase 4Results posted
• Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate CancerCompletedNCT01081873Results posted
• Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)CompletedNCT01078545Results posted
• Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate CancerCompletedNCT01076335Phase 2Results posted
• Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate CancerCompletedNCT01071915Phase 3Results posted
• Phase 3 Study of Immunotherapy to Treat Advanced Prostate CancerCompletedNCT01057810Phase 3Results posted
• Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate CancerCompletedNCT01054079Phase 2Results posted
• Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After DocetaxelCompletedNCT01051570Phase 2Results posted
• Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate CancerCompletedNCT01040624Not applicableResults posted
• Ketoconazole and Dexamethasone in Prostate CancerCompletedNCT01036594Phase 2Results posted
• Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, EffectivenessCompletedNCT01036321Phase 2Results posted
• Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate CancerCompletedNCT01026623Phase 1/2Results posted
• Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy ResultCompletedNCT01024959Not applicableResults posted
• Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate CancerCompletedNCT01023061Phase 2Results posted
• Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate CancerCompletedNCT01020448Phase 3Results posted
• Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate CancerTerminatedNCT01020305Phase 1/2Results posted
• Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer PatientsCompletedNCT01008969Not applicableResults posted
• Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate CancerTerminatedNCT00996502Phase 1/2Results posted
• A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate CancerCompletedNCT00992186Phase 2Results posted
• Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate CancerCompletedNCT00988208Phase 3Results posted
• Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate CancerTerminatedNCT00985738Phase 2Results posted
• Hypofractionated SBRT For Prostate CancerCompletedNCT00977860Not applicableResults posted
• Figitumumab Combined With Pegvisomant For Advanced Solid TumorsTerminatedNCT00976508Phase 1Results posted
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based ChemotherapyCompletedNCT00974311Phase 3Results posted
• A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate CancerCompletedNCT00972309Phase 1Results posted
• Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate CancerCompletedNCT00970203Phase 2Results posted
• A Long Term Safety Study of Degarelix in Patients With Prostate CancerCompletedNCT00967018Phase 3Results posted

← Prostatic Neoplasms overview